Status:
COMPLETED
Ketosis Prone Diabetes in African-Americans
Lead Sponsor:
Emory University
Conditions:
Ketosis Prone Diabetes
Diabetic Ketoacidosis
Eligibility:
All Genders
19-65 years
Brief Summary
Over 50% of obese African-Americans (AA) presenting with newly diagnosed, severe hyperglycemia and/or unprovoked diabetic ketoacidosis (DKA) display clinical, metabolic, and immunogenetic features of ...
Detailed Description
More than half of obese African-Americans (AA) with newly diagnosed diabetes presenting with diabetic ketoacidosis (DKA) display clinical, metabolic, and immunogenetic features of type 2 diabetes duri...
Eligibility Criteria
Inclusion
- 36 Obese AA subjects with DKA or severe hyperglycemia and 8 obese nondiabetic subjects, age 19-65. All studies will be performed in the GCRC at Grady Memorial Hospital.
- Subjects with a BMI ≥ 28 kg/m2 will be included.
- Diagnostic criteria for DKA will include:
- a plasma glucose \> 250 mg/dl,
- a venous pH \< 7.30,
- a serum bicarbonate \< 18 mEq/l, and
- high serum ketones.
- Obese hyperglycemic patients will have:
- a blood glucose on admission \> 400 mg/dl,
- a serum bicarbonate \> 18 mEq/l, and
- negative ketones.
Exclusion
- Patients with significant medical or surgical illness, including but not limited to myocardial ischemia, congestive heart failure, chronic renal insufficiency, liver failure, and infectious processes;
- Patients with recognized endocrine disorders, such as hypercortisolism, acromegaly, or hyperthyroidism;
- Bleeding disorders, or abnormalities in coagulation studies;
- Pregnancy.
Key Trial Info
Start Date :
May 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2010
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00426413
Start Date
May 1 2007
End Date
August 1 2010
Last Update
November 13 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Grady Memorial Hospital
Atlanta, Georgia, United States, 30303